These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. T cells, adhesion molecules and modulation of apoptosis in visceral leishmaniasis glomerulonephritis. Costa FA, Prianti MG, Silva TC, Silva SM, Guerra JL, Goto H. BMC Infect Dis; 2010 May 11; 10():112. PubMed ID: 20459816 [Abstract] [Full Text] [Related]
7. Regulatory T cells, Cytotoxic T lymphocytes and a T(H)1 cytokine profile in dogs naturally infected by Leishmania infantum. Cortese L, Annunziatella M, Palatucci AT, Rubino V, Piantedosi D, Di Loria A, Ruggiero G, Ciaramella P, Terrazzano G. Res Vet Sci; 2013 Dec 11; 95(3):942-9. PubMed ID: 24079840 [Abstract] [Full Text] [Related]
8. Diminished CD4+/CD25+ T cell and increased IFN-gamma levels occur in dogs vaccinated with Leishmune in an endemic area for visceral leishmaniasis. de Lima VM, Ikeda FA, Rossi CN, Feitosa MM, Vasconcelos RO, Nunes CM, Goto H. Vet Immunol Immunopathol; 2010 Jun 15; 135(3-4):296-302. PubMed ID: 20132994 [Abstract] [Full Text] [Related]
9. Recovery of antigen-specific T cell responses from dogs infected with Leishmania (L.) infantum by use of vaccine associated TLR-agonist adjuvant. Schaut RG, Grinnage-Pulley TL, Esch KJ, Toepp AJ, Duthie MS, Howard RF, Reed SG, Petersen CA. Vaccine; 2016 Oct 17; 34(44):5225-5234. PubMed ID: 27665354 [Abstract] [Full Text] [Related]
10. Light and electron microscopic analysis of consecutive renal biopsy specimens from leishmania-seropositive dogs. Aresu L, Benali S, Ferro S, Vittone V, Gallo E, Brovida C, Castagnaro M. Vet Pathol; 2013 Sep 17; 50(5):753-60. PubMed ID: 22961886 [Abstract] [Full Text] [Related]
11. Activation of autophagy and nucleotide-binding domain leucine-rich repeat-containing-like receptor family, pyrin domain-containing 3 inflammasome during Leishmania infantum-associated glomerulonephritis. Esch KJ, Schaut RG, Lamb IM, Clay G, Morais Lima ÁL, do Nascimento PR, Whitley EM, Jeronimo SM, Sutterwala FS, Haynes JS, Petersen CA. Am J Pathol; 2015 Aug 17; 185(8):2105-17. PubMed ID: 26079813 [Abstract] [Full Text] [Related]
14. Long-lasting protection against canine visceral leishmaniasis using the LiESAp-MDP vaccine in endemic areas of France: double-blind randomised efficacy field trial. Lemesre JL, Holzmuller P, Gonçalves RB, Bourdoiseau G, Hugnet C, Cavaleyra M, Papierok G. Vaccine; 2007 May 22; 25(21):4223-34. PubMed ID: 17395339 [Abstract] [Full Text] [Related]
18. Phenotypic features of circulating leucocytes as immunological markers for clinical status and bone marrow parasite density in dogs naturally infected by Leishmania chagasi. Reis AB, Teixeira-Carvalho A, Giunchetti RC, Guerra LL, Carvalho MG, Mayrink W, Genaro O, Corrêa-Oliveira R, Martins-Filho OA. Clin Exp Immunol; 2006 Nov 22; 146(2):303-11. PubMed ID: 17034583 [Abstract] [Full Text] [Related]
20. A recombinant cysteine proteinase from Leishmania (Leishmania) chagasi as an antigen for delayed-type hypersensitivity assays and serodiagnosis of canine visceral leishmaniasis. Pinheiro PH, Pinheiro AN, Ferreira JH, Costa FA, Katz S, Barbiéri CL. Vet Parasitol; 2009 May 26; 162(1-2):32-9. PubMed ID: 19269098 [Abstract] [Full Text] [Related] Page: [Next] [New Search]